You are here: Welcome » Sudeep Gill

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
sudeep_gill [2022/05/06 20:20]
liam [Funding]
sudeep_gill [2022/05/07 00:29] (current)
liam [Sudeep Gill]
Line 3: Line 3:
 {{ ::gill_sudeep_2019.jpeg?200|}} {{ ::gill_sudeep_2019.jpeg?200|}}
  
-Dr. **Sudeep Gill** is a Canadian geriatrician and health services researcher based in [[canada:Ontario:Kingston]], [[canada:Ontario]].+Dr. **Sudeep S. Gill**, MD MSc FRCPC is a Canadian geriatrician and health services researcher based in [[canada:Ontario:Kingston]], [[canada:Ontario]].
  
 ===== Career and Affiliations ===== ===== Career and Affiliations =====
Line 9: Line 9:
 ==== Queen's University ==== ==== Queen's University ====
  
-Gill is an associate professor in the Department of Medicine at [[Queen's University]].((//Gill | Department of Medicine | School of Medicine.// Queen’s University. Retrieved May 5, 2022, from https://deptmed.queensu.ca/people/sudeep-gill))+Gill is an associate professor in the Division of Geriatric Medicine, with cross-appointment in the Department of Public Health Sciences in the Department of Medicine at [[Queen's University]].((//Gill | Department of Medicine | School of Medicine.// Queen’s University. Retrieved May 5, 2022, from https://archive.ph/zYmh6))
  
 +He he has been a member of Senate Advisory Research Committee (2009-2012), a member of the AHSC AFP Innovation Fund grant application review committee, and a member of the Department of Medicine Promotions Committee.
 ==== ICES ==== ==== ICES ====
  
-Gill is a senior adjunct scientist at the [[Institute for Clinical Evaluative Sciences]] (ICES).+Gill is a senior adjunct scientist at the [[Institute for Clinical Evaluative Sciences]] (ICES).((//Sudeep Gill.// Institutes for Clinical Evaluative Sciences. Retrieved May 6, 2022, from https://www.ices.on.ca/About-ICES/ICES-Scientists/G/Sudeep-Gill)) 
 + 
 +==== Clinical Work ==== 
 + 
 +Gill works in Specialized Geriatrics services at [[Providence Care]] (inpatient geriatric rehabilitation and outpatient geriatric medicine clinics) and [[Kingston Health Sciences Centre|Kingston General Hospital]] (geriatrics consult service).((//Doctor Gill, Sudeep S - Geriatric Medicine.// (2021, August 13). South East Local Health Integration Network. https://archive.ph/iwdoG)) He previously served as Chair of the Providence Care Pharmacy and Therapeutics Committee. 
 + 
 +Both facilities raise money through the [[University Hospitals Kingston Foundation]], including from a variety of [[pharmaceutical companies]].((//Recognizing Your Contribution.// Kingston University Hospital Foundation. Retrieved May 4, 2022, from https://web.archive.org/web/20220504073124/https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution)) 
 + 
 +==== Government of Ontario ==== 
 + 
 +Gill has been a member of the [[Committee to Evaluate Drugs]] (CED), an advisory committee to the [[Ontario Ministry of Health and Long-Term Care]] on decisions about medications included on the province’s publicly funded formulary.
  
 ==== Ontario COVID-19 Science Advisory Table ==== ==== Ontario COVID-19 Science Advisory Table ====
Line 23: Line 34:
 ==== Funding ==== ==== Funding ====
  
-Gill has co-authored research that was funded by the [[Canadian Lung Association]].((Vozoris, N. T., Pequeno, P., Li, P., Austin, P. C., Stephenson, A. L., O’Donnell, D. E., Gill, S. S., Gershon, A. S., & Rochon, P. A. (2021). //Morbidity and mortality associated with prescription cannabinoid drug use in COPD.// Thorax, 76(1), 29–36. https://doi.org/10.1136/thoraxjnl-2020-215346)) The CLA is partnered with [[Immunize Canada]] and funded by [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Pfizer]], [[medical_technology_companies:ProResp]], [[pharmaceutical_companies:Roche]] and [[medical_technology_companies:Trudell Medical]].((//About Us.// (2016, December 10). Canadian Lung Association. https://archive.ph/XNGx1)) ((//2020/2021 Annual Report.// Canadian Lung Association. Retrieved May 5, 2022, from https://web.archive.org/web/20220505235346/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2020_2021_EN_FIN.pdf)) ((//2019/2020 Annual Report.// Wayback Machine; Canadian Lung Association. Retrieved May 5, 2022, from https://web.archive.org/web/20220505235859/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2019_2020_EN.pdf)) ((//2017-2018 Annual Report.// Canadian Lung Association. Retrieved May 6, 2022, from https://web.archive.org/web/20220506181857/https://www.lung.ca/sites/default/files/CLA_AnnualReport2017_2018_EN_FINALSEPT21.pdf))+Gill has co-authored research that was funded by the [[Canadian Lung Association]].((Vozoris, N. T., Pequeno, P., Li, P., Austin, P. C., Stephenson, A. L., O’Donnell, D. E., Gill, S. S., Gershon, A. S., & Rochon, P. A. (2021). //Morbidity and mortality associated with prescription cannabinoid drug use in COPD.// Thorax, 76(1), 29–36. https://doi.org/10.1136/thoraxjnl-2020-215346)) The CLA is partnered with [[Immunize Canada]] and funded by [[pharmaceutical_companies:Actelion]], [[pharmaceutical_companies:AbbVie]], [[AllerGen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[GE Healthcare]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Grifols]], [[pharmaceutical_companies:Hospira]], [[pharmaceutical_companies:Intermune]], [[medical_technology_companies:ManthaMed]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pediapharm]], [[pharmaceutical_companies:Pfizer]], [[medical_technology_companies:ProResp]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Takeda]], [[pharmaceutical_companies:Teva]], [[medical_technology_companies:Trudell Medical]], [[pharmaceutica;_companies:Unither Biotech]] and [[pharmaceutical_companies:Vertex]].((//About Us.// (2016, December 10). Canadian Lung Association. https://archive.ph/XNGx1)) ((//2020/2021 Annual Report.// Canadian Lung Association. Retrieved May 5, 2022, from https://web.archive.org/web/20220505235346/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2020_2021_EN_FIN.pdf)) ((//2019/2020 Annual Report.// Wayback Machine; Canadian Lung Association. Retrieved May 5, 2022, from https://web.archive.org/web/20220505235859/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2019_2020_EN.pdf)) ((//2017-2018 Annual Report.// Canadian Lung Association. Retrieved May 6, 2022, from https://web.archive.org/web/20220506181857/https://www.lung.ca/sites/default/files/CLA_AnnualReport2017_2018_EN_FINALSEPT21.pdf)) ((//2015/2016 Annual Report.// Canadian Lung Association. Retrieved May 6, 2022, from https://web.archive.org/web/20220506182758/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2015_2016_EN.pdf)) ((//2014/2015 Annual Report.// Canadian Lung Association. Retrieved May 6, 2022, from https://web.archive.org/web/20160413195706/http://www.lung.ca/file/1172/download?token=B8JBiFLw))
Back to top